BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Trovagene Presents Data Showing Sensitivity of Triple Negative Breast Cancer (TNBC) Cell Lines to PCM-075 and Synergy with Zytiga® at San Antonio Breast Cancer Symposium (SABCS)

  The presentation data indicates that PCM-075 in combination with anti-androgen, abiraterone acetate are synergistic in inducing cell death within an AR+ TNBC cell line.

  December 8, 2017

   · 

  6 min read
• BioCapital

  QIAGEN to Transfer U.S. Listing of Global Shares to NYSE

  QIAGEN N.V. today announced that it is transferring the U.S. listing of its global shares to the NYSE from the NASDAQ Global Market.

  December 8, 2017

   · 

  1 min read
• 

  Drug Development

  Lilly’s Cyramza Fails to Improve Overall Survival in Phase III Gastric Cancer Study

  The trial met its primary endpoint of progression-free survival but did not improve overall survival, a secondary endpoint.

  December 8, 2017

   · 

  22 min read
• Lone Star Bio

  Seno Medical Instruments Announces New Data Demonstrating That Imagio Opto-Acoustic Breast Imaging System Delivers Critical Diagnostic and Prognostic Information About Tumor Subtypes

  The prospective, multi-center study was conducted at 16 centers in the United States.

  December 8, 2017

   · 

  5 min read
• Biotech Bay

  Rigel Pharma Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

  Rigel today announced that on December 4, 2017 the Compensation Committee of Rigel’s Board of Directors approved the grant of inducement stock options to purchase an aggregate of 60,000 shares of common stock to one new employee.

  December 8, 2017

   · 

  2 min read
• 

  Deals

  Ex-Genentech Employees’ Denali Breaks 2017 IPO Records, Raises $250M

  With the raise, the company’s market valuation is currently $1.7B.

  December 8, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Biotech Hedge Fund Titan, Isaly, Steps Down Amid Sexual Harassment Claims

  In the wake of sexual harassment allegations, OrbiMed Advisors’ founder and managing partner Sam Isaly has stepped down from his position.

  December 8, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Mysterious NuBiyota Inks Lease for Former Pfizer Campus

  The former Pfizer campus in New York’s Hudson Valley owned by Industrial Realty Group has gained a new tenant.

  December 8, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Spark’s Good Week Continues With Signing of Huge Lease Near HQ

  Spark Therapeutics is having a really good week in what has been a very good year.

  December 8, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  BioCapital

  Fully Loaded With Nearly 500 Employees in Rockville, GlaxoSmithKline Chief Lays Out 2018 Goals

  Glaxo has a bold future planned for its R&D facility in Maryland.

  December 8, 2017

   · 

  3 min read

   · 

  Alex Keown